Hepatitis C Virus Genotyping Using an Oligonucleotide Microarray Based on the NS5B Sequence

The genotype of the hepatitis C virus (HCV) is essential for determining treatment duration in clinical practice and for epidemiological and clinical studies. Currently, few genotyping assays that determine the HCV subtype are available. This report describes a microarray-based molecular technique f...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical Microbiology 2010-11, Vol.48 (11), p.3910-3917
Main Authors: Gryadunov, Dimitry, Nicot, Florence, Dubois, Martine, Mikhailovich, Vladimir, Zasedatelev, Alexander, Izopet, Jacques
Format: Article
Language:English
Subjects:
Genotype
Hepacivirus - classification
Hepacivirus - genetics
Hepacivirus - isolation & purification
Hepatitis C - epidemiology
Hepatitis C - virology
Hepatitis C virus
Humans
Oligonucleotide Array Sequence Analysis - methods
Sensitivity and Specificity
Sequence Analysis, DNA
Viral Nonstructural Proteins - genetics
Virology
Virology - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The genotype of the hepatitis C virus (HCV) is essential for determining treatment duration in clinical practice and for epidemiological and clinical studies. Currently, few genotyping assays that determine the HCV subtype are available. This report describes a microarray-based molecular technique for identifying the HCV genotype and subtype. It uses low-density hydrogel-based biochips containing genotype- and subtype-specific oligonucleotides based on the sequences of the NS5B region of the HCV genome. The biochip contains 120 oligonucleotides that identify genotypes 1 to 6 and 36 (1a, 1b, 1c, 1d, 1e, 2a, 2b, 2c, 2d, 2i, 2j, 2k, 2l, 2m, 3a, 3b, 3k, 4a, 4c, 4d, 4f, 4h, 4i, 4k, 4n, 4o, 4p, 4r, 4t, 5a, 6a, 6b, 6d, 6g, 6h, and 6k) subtypes. The procedure included amplification of a 380-nucleotide (nt) fragment of NS5B and its hybridization on the biochip. Tests on 345 HCV-positive samples showed that the assay agreed with NS5B sequencing 100% for the genotype and 99.7% for the subtype. The hybridization on the microarray and the NS5B sequence were in 100% agreement for identifying the most common subtypes, 1a, 1b, 4a, 4d, and 3a. This approach is a promising tool for HCV genotyping, especially for implementing the new anti-HCV drugs that require accurate identification of clinically relevant subtypes.
ISSN:0095-1137
1098-660X
DOI:10.1128/JCM.01265-10